Who are they?

From here.

The former CEO of Alba Therapeutics, Blake Paterson, has put together a $22 million A round to launch his new biotech in Baltimore. Describing itself as a drug developer devoted to finding new treatments for the human nervous system, Cerecor says it has gathered a group of unnamed "accredited investors" to back the company, including members of its board.

Sounds interesting? YES! It looks like we have recognized a Partizan of a Death Valley! Wait a minute... What is it?

The board includes some recognizable faces, including Sol Barer, the former CEO of Celgene. Another board member, Isaac Blech, is credited with helping to establish Celgene, ICOS and Nova Pharmaceutical. The last heard from Alba was a press release back in early 2011 laying out an option deal that Cephalon had struck for acquiring all the assets related to its lead therapy, larazotide acetate, following a Phase IIb for celiac disease. Paterson, who co-founded Alba, was replaced by one of the venture backers back in 2008.

You are saying Celgene? Nova? Alba? Well, I am a little bit disappointed – No partizans here. Probably these gentlemen are very respectful professionals in their business, but they unfortunately are Big Pharma's allies, but not partizans, definitively not!